Patents by Inventor Fritz Rudert

Fritz Rudert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
    Patent number: 7049135
    Abstract: The present invention relates to methods for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex by screening for polyphage particles. Furthermore, the invention relates to products and uses thereof for the identification of nucleic acid sequences in accordance with the present invention.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: May 23, 2006
    Assignee: Morphosys AG
    Inventors: Fritz Rudert, Liming Ge, Vic Ilag
  • Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
    Publication number: 20040048383
    Abstract: The present invention relates to methods for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex by screening for polyphage particles. Furthermore, the invention relates to products and uses thereof for the identification of nucleic acid sequences in accordance with the present invention.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 11, 2004
    Inventors: Fritz Rudert, Liming Ge, Vic Ilag
  • Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly) peptide complex
    Patent number: 6667150
    Abstract: The present invention relates to methods for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex by screening for polyphage particles. Furthermore, the invention relates to products and uses thereof for the identification of nucleic acid sequences in accordance with the present invention.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: December 23, 2003
    Assignee: Morphosys AG
    Inventors: Fritz Rudert, Liming Ge, Vic Ilag
  • CD95 regulatory gene sequences
    Patent number: 5912168
    Abstract: Regulatory DNA sequences that silence and enhance transcription of coding portions of the CD95 gene, which is instrumental in apoptosis, are disclosed. Proteinaceous transcription factors that bind to the silencer and enhancer regulatory sequences are also disclosed and are useful for modulating the expression of CD95 or other proteins. Methods for regulating apoptosis have therapeutic and prophylactic applications for a variety of disorders, including cancer, viral and retroviral infections, neurodegenerative disorders, immune system dysfunction, and other disorders.
    Type: Grant
    Filed: August 30, 1996
    Date of Patent: June 15, 1999
    Assignee: Genesis Research & Development Corporation Limited
    Inventors: James D. Watson, Fritz Rudert